Bank of America
BIB icon

Bank of America’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History

Bank of America’s Portfolio BIB Stock Details BIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-10
Closed -$575 – 8214
2024
Q1 		$575 Buy
+10
New +$580 ﹤0.01% 7263
2022
Q3 		– Sell
-400
Closed -$19K – 7831
2022
Q2 		$19K Buy
+400
New +$20.4K ﹤0.01% 7197
2021
Q3 		– Sell
-1
Closed – – 8105
2021
Q2 		$0 Buy
+1
New +$87 ﹤0.01% 7748
2020
Q2 		– Sell
-1,700
Closed -$79K – 6824
2020
Q1 		$79K Buy
+1,700
New +$94.7K ﹤0.01% 5644
2019
Q2 		– Sell
-200
Closed -$11K – 7177
2019
Q1 		$11K Buy
+200
New +$10.8K ﹤0.01% 6621
2018
Q4 		– Sell
-200
Closed -$14K – 7106
2018
Q3 		$14K Buy
+200
New +$13.1K ﹤0.01% 6579
2018
Q2 		– Sell
-80
Closed -$4K – 7084
2018
Q1 		$4K Buy
+80
New +$4.79K ﹤0.01% 6798
2017
Q4 		– Sell
-600
Closed -$33.8K – 7027
2017
Q3 		$37K Sell
600
-1,000
-63% -$56.9K ﹤0.01% 6058
2017
Q2 		$86K Buy
1,600
+500
+45% +$24.4K ﹤0.01% 5659
2017
Q1 		$53K Hold
1,100
– – ﹤0.01% 5902
2016
Q4 		$44K Sell
1,100
-600
-35% -$25.6K ﹤0.01% 5988
2016
Q3 		$82K Buy
1,700
+600
+55% +$28.5K ﹤0.01% 5518
2016
Q2 		$42K Sell
1,100
-1,050
-49% -$45.3K ﹤0.01% 5904
2016
Q1 		$87K Sell
2,150
-730
-25% -$32.3K ﹤0.01% 5546
2015
Q4 		$206K Sell
2,880
-3,270
-53% -$218K ﹤0.01% 5361
2015
Q3 		$358K Buy
6,150
+3,768
+158% +$321K ﹤0.01% 5017
2015
Q2 		$215K Sell
2,382
-640
-21% -$55.1K ﹤0.01% 5210
2015
Q1 		$240K Buy
3,022
+722
+31% +$53.5K ﹤0.01% 4812
2014
Q4 		$144K Buy
2,300
+90
+4% +$5.28K ﹤0.01% 5622
2014
Q3 		$115K Hold
2,210
– – ﹤0.01% 5886
2014
Q2 		$103K Buy
2,210
+300
+16% +$11.8K ﹤0.01% 6116
2014
Q1 		$76K Buy
+1,910
New +$86.7K ﹤0.01% 6177
2013
Q3 		– Sell
-1,000
Closed -$23K – 7869
2013
Q2 		$23K Buy
+1,000
New +$22.8K ﹤0.01% 6903

Other funds holding BIB

Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
CIA
Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
WWM
Westwood Wealth Management Los Angeles, California $255M AUM 54.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Bank of America's BIB Position: Q2 2024 in Review

Bank of America sold out of ProShares Ultra NASDAQ Biotechnology (BIB) in Q2 2024, closing a stake of 10 shares — an estimated $575 sold.

Bank of America first reported a position in BIB in Q2 2013 and held it in 23 quarters. The position peaked at $358K in Q3 2015. 24 funds tracked by Wall St. Rank hold BIB as of Q2 2024.

  • Bank of America reported no remaining ProShares Ultra NASDAQ Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Bank of America sold 10 ProShares Ultra NASDAQ Biotechnology shares in Q2 2024, an estimated $575.
  • Bank of America first reported a position in ProShares Ultra NASDAQ Biotechnology in Q2 2013 and held it in 23 quarters.
  • Bank of America's ProShares Ultra NASDAQ Biotechnology position peaked at $358K in Q3 2015.
  • 24 funds tracked by Wall St. Rank held ProShares Ultra NASDAQ Biotechnology as of Q2 2024.

Based on Bank of America's 13F filing for Q2 2024, filed 14 Aug 2024.